Advertisement

Topics

Saphenous Vein Graft Aneurysm 10 Years After Paclitaxel-Eluting Stent Implantation.

08:00 EDT 1st May 2017 | BioPortfolio

Summary of "Saphenous Vein Graft Aneurysm 10 Years After Paclitaxel-Eluting Stent Implantation."

A patient underwent paclitaxel-eluting implantation for a saphenous vein graft stenosis. A follow-up angiogram at 8 months demonstrated no restenosis, with multifocal peristent contrast staining. After 10 years, a saphenous vein graft aneurysm was revealed within the stented segment. This late complication should be kept in mind when evaluating patients who have received prior drug-eluting stents.

Affiliation

Journal Details

This article was published in the following journal.

Name: The Journal of invasive cardiology
ISSN: 1557-2501
Pages: E63

Links

DeepDyve research library

PubMed Articles [9469 Associated PubMed Articles listed on BioPortfolio]

Aneurysmal degeneration of an aorto-renal bypass for Takayasu renal artery stenosis: a novel endovascular intervention.

We report an aneurysm degeneration of a vein graft in a previous aortorenal bypass performed five years earlier for severe right renal artery stenosis due to Takayasu arteritis. The patient was a 31-y...

Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation in vitro and prevents vein graft neointimal formation ex vivo and in vivo.

Poor long-term patency of vein grafts remains an obstacle in coronary artery bypass grafting (CABG) surgery using an autologous saphenous vein graft. Recent studies have revealed that miR-126-3p promo...

Thrombectomy for late occlusion of high flow extracranial-intracranial saphenous vein bypass graft after 27 years of patency.

High flow extracranial-intracranial (EC-IC) bypass with a saphenous vein graft (SVG) has been used for more than 40 years in patients with giant aneurysms of the posterior circulation refractory to me...

Limiting Injury During Saphenous Vein Graft Preparation For Coronary Arterial Bypass Prevents Metabolic Decompensation.

Standard harvest and preparation of human saphenous vein (HSV) for autologous coronary and peripheral arterial bypass procedures is associated with injury and increased oxidative stress that negativel...

Development of Angiosarcoma in a Saphenous Vein Graft Following Femoral to Above-knee Popliteal Artery Bypass.

Angiosarcoma is an exceedingly rare and aggressive neoplasm. Due to early metastasis even in low-grade tumors, it is associated with poor survival. We report a late development of an angiosarcoma in a...

Clinical Trials [5139 Associated Clinical Trials listed on BioPortfolio]

The SOS (Stenting Of Saphenous Vein Grafts) Trial

The main purpose of this study is to determine whether implantation of a paclitaxel-eluting stent (Taxus™) in saphenous vein graft lesions will reduce the incidence of in-stent restenosi...

Comparison of Safety and Efficacy of Two Different Drug Eluting Stents Implanted Into Saphenous Vein Grafts

Drug eluting stents significantly reduced the rate of in-stent restenosis in coronary arteries. There are several kinds of DES i.e. eluting the drug either from stable or biodegradable pol...

A Meta-analysis of Drug Eluting Stents Versus Bare Metal Stents in Saphenous Vein Graft Disease

A meta-analysis to compare outcomes of drug eluting stents (DES) versus bare metal stent (BMS) in saphenous vein graft (SVG) disease.

Use of the GARDEX™ Embolic Protection Device During Percutaneous Coronary Interventions of Saphenous Vein Graft

This is a multi center, prospective study designed to demonstrate the safety and performance of the GARDEX Embolic Protection System when used as an adjunctive device during saphenous vein...

Evaluating the Role of Thrombin in Saphenous Vein Graft Failure After Heart Bypass Surgery

Heart bypass surgery, also known as coronary artery bypass graft (CABG) surgery, creates a detour around the blocked part of a heart artery to restore blood supply to the heart muscle. The...

Medical and Biotech [MESH] Definitions

The vein which drains the foot and leg.

A short thick vein formed by union of the superior mesenteric vein and the splenic vein.

Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.

An injectable formulation of albumin-bound paclitaxel NANOPARTICLES.

The immune responses of a host to a graft. A specific response is GRAFT REJECTION.

Advertisement
Quick Search
Advertisement
Advertisement

 
DeepDyve research library

Relevant Topics

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Searches Linking to this Article